Patent · US Active

IL6R/IL6 chimera for therapy of chemotherapy-induced peripheral neuropathy

US8394367B2 · kind B2 · utility

0Cited by
4References
61Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 28, 2005
Grant dateMar 12, 2013
Priority date—
Expiry dateMay 11, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to the use of IL-6R/IL-6 chimera in chemotherapy induced neuropathy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.